Jay Caplan

Company: Fractyl Therapeutics

Job title: President

Seminars:

Why Physiologically-Regulated GLP-1 May Improve the Efficacy and Tolerability of Weight Loss Therapeutics 11:00 am

Mimicking the physiologic secretion profile of GLP-1 to provide receptor agonism when it is needed, for improved efficacy and tolerability Targeting individual patient needs by developing a platform for several multi-agonist therapies Reducing treatment burden with a one-time, life-long therapyRead more

day: Day One